Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-08-22 | New | $1,275,000 | Unknown | Debt Only | SEC link | |
| 2024-12-26 | Amended | $5,824,155 | $4,195,757 | Equity Only | 06b 4a5 | SEC link |
| 2024-08-12 | New | $1,628,398 | $1,628,398 | Equity Only | 06b 4a5 | SEC link |
| 2023-01-26 | New | $3,088,234 | $3,088,234 | Equity Only | 06b 4a5 | SEC link |
| 2021-08-24 | New | $4,344,675 | $4,344,675 | Equity Only | 06b 4a5 | SEC link |
| 2019-02-08 | New | $2,160,000 | $2,160,000 | Equity Only | 06b 4a5 | SEC link |
| 2018-09-07 | New | $2,160,000 | $2,160,000 | Equity Only | 06b 4a5 | SEC link |
| Name | Role |
|---|---|
| Chris Arendt | Director |
| James Demetriades | Director |
| Nicholas T. Iatropoulos | Director |
| Jack Lepping | Director |
| Patrick T. Mooney | Director, Executive |
| Christopher Natale | Executive |
| Michael Poisel | Director |
| Todd T. Thomson | Director |